2013年

1. Yamasaki K, Chuang VT, Maruyama T, Otagiri M.
   Albumin-drug interaction and its clinical implication.
   Biochim Biophys Acta. 2013 1830(12):5435-43.
2. Maeda H, Nakamura H, Fang J.
   The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.
   Adv Drug Deliv Rev. 2013 65(1):71-9.
3. Altaf, H. Aldawsari, Z. M. Banjar, M. Anraku, D. Iohara, M. Otagiri, K. Uekama, F. Hirayama.
   Preparation of soluble stable C60/human serum albumin nanoparticles via cyclodextrin complexation and their reactive oxygen production characteristics.
   Life Sci., 93, 277-282 (2013).
4. H. Aldawsari, A. Altaf, Z. M. Banjar, D. Iohara, M. Nakabayashi, M. Anraku, K. Uekama and F. Hirayama.
   Crystallization of A New Polymorph of Acetohexamide from 2-Hydroxybutyl-β-cyclodextrin Solution: Form VI with A High Aqueous Solubility.
   Int. J. Pharm., 453, 315-321 (2013).
5. 上釜兼人、平山文俊、安楽誠、庵原大輔
   各種薬物の製剤特性改善におけるシクロデキストリンの有用性
   シクロデキストリンの科学と技術, 寺尾 啓二，池田 宰（監修）,　シーエムシー出版, 東京, 2013, pp. 124-133.